Seen 'Gaza: Doctors Under Attack'?
Utterly horrific documentary which demands investigation into the deliberate targeting, torture & alleged murder of healthcare workers in #Gaza
https://t.co/HfGDplYm8L
🚨 Reminder - there is still time to register for our FREE Autoimmune CAR T Symposium 🚨
🗓️ Wed 20th November
⏰ 12.00 registration / lunch, 12.30 start. Concluding at 5.15pm and will be followed by drinks and networking opportunities
🔗 https://t.co/TmgQbbfoIr
Tolebrutinib does have significant effect and confirmed disability progression in both secondary progressive and relapsing remitting MS with 30% reduction in CDP at 6 months. Appear independent of relapses. Liver impairment remains concern, occurs in first 90 days
Reassuring data from SOPRANINO study in mothers receiving Ocrelizumab while breastfeeding there was negligible transfer into breast milk, undetectable levels in baby’s serum and B cells within normal limits in baby
@GavinGiovannoni There is good data which suggest that scanning the spine annually in people who have no new symptoms is extremely unlikely to show a new change. Having said that, scanning the cord every 2-3 years is reasonable, logical, and keeps our Neuroradiologists sanity!